

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 20mg | 360 pills | €1.41 | €636.66 €509.33 | |
| 20mg | 270 pills | €1.39 | €465.32 €372.25 Best Price | |
| 20mg | 180 pills | €1.43 | €321.03 €256.82 | |
| 20mg | 120 pills | €1.54 | €230.85 €184.68 | |
| 20mg | 90 pills | €1.70 | €191.17 €152.93 | |
| 20mg | 60 pills | €2.01 | €149.68 €119.75 | |
| 20mg | 30 pills | €2.87 | €108.20 €86.56 | |
| 30mg | 360 pills | €2.57 | €1,157.91 €926.33 | |
| 30mg | 270 pills | €2.86 | €964.92 €771.94 | |
| 30mg | 180 pills | €3.17 | €714.22 €571.38 | |
| 30mg | 120 pills | €3.23 | €485.16 €388.13 | |
| 30mg | 90 pills | €3.39 | €382.35 €305.88 | |
| 30mg | 60 pills | €3.56 | €266.92 €213.54 | |
| 30mg | 30 pills | €3.97 | €149.68 €119.75 | |
| 40mg | 270 pills | €2.41 | €811.62 €649.29 | |
| 40mg | 180 pills | €2.68 | €604.20 €483.36 | |
| 40mg | 120 pills | €2.99 | €447.28 €357.83 | |
| 40mg | 90 pills | €3.30 | €371.53 €297.22 | |
| 40mg | 60 pills | €3.68 | €275.94 €220.75 | |
| 40mg | 30 pills | €4.85 | €182.15 €145.72 | |
| 60mg | 270 pills | €3.79 | €1,278.76 €1,023.00 Popular | |
| 60mg | 180 pills | €3.78 | €851.30 €681.04 | |
| 60mg | 120 pills | €4.21 | €631.25 €505.00 | |
| 60mg | 90 pills | €4.68 | €526.64 €421.31 | |
| 60mg | 60 pills | €5.19 | €389.57 €311.65 | |
| 60mg | 30 pills | €5.77 | €216.42 €173.13 |
Disclaimer: This information is intended for patient education and does not replace professional medical advice. Always consult a healthcare professional for personal medical guidance.
Cymbalta is the brand name for duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat mood disorders and certain chronic pain conditions.
It belongs to the SNRI class, meaning it increases the levels of two brain chemicals, serotonin and norepinephrine, to help improve mood and modulate pain signals.
In Ireland, duloxetine is typically prescribed by a clinician and dispensed by a pharmacist, with monitoring for side effects and potential interactions. It may be used for major depressive disorder, generalized anxiety disorder, diabetic neuropathy, fibromyalgia, and chronic musculoskeletal pain among other indications.
Therapy should be tailored to the individual, balancing benefit with potential risks. Read the official patient leaflet and discuss any questions with a pharmacist or doctor before starting treatment.
Like many medicines, duloxetine can interact with other drugs, alcohol, or certain medical conditions. A clinician may adjust the dose, monitor liver function, and review other medicines to reduce risk. If new symptoms occur, seek medical advice promptly.
Duloxetine is approved for major depressive disorder and generalized anxiety disorder in many healthcare systems, including Ireland. It may also be prescribed for related mood and anxiety conditions under clinical guidance.
As with all antidepressants, treatment response can vary. Some people notice improvement within a few weeks, while others may require longer to see the full effect. Do not adjust the dose or stop therapy without medical instruction.
When duloxetine is used for mood disorders, clinicians often begin with a cautious dose and titrate based on tolerance and response. Regular follow-up helps ensure the balance of benefits and side effects is appropriate for the individual.
In addition to mood and anxiety benefits, the drug’s effect on certain nerve pathways may influence how painful sensations are processed. This dual action underpins several non-depressant indications that clinicians sometimes consider in complex cases.
If you have questions about whether this medicine is right for a specific mood or anxiety condition, consult your healthcare professional. For Ireland-specific guidance, your pharmacist can provide country-tailored information and resources.
Duloxetine is used to treat certain chronic pain conditions, including diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain. It can help reduce pain intensity and improve daily function for some patients.
Pain relief from duloxetine is not the same as a painkiller; it works by a biochemical mechanism that modulates pain signaling in the brain and spinal cord. The result can be a softer perception of pain and greater physical comfort during daily activities.
Like mood-related uses, pain indications require careful dosing and monitoring. Effectiveness and tolerability must be assessed over several weeks, and adjustments may be needed if side effects occur or if pain control is insufficient.
In Ireland, access to duloxetine for pain conditions typically follows specialist or GP assessment, with a prescription and ongoing supervision. The clinician will weigh potential benefits against risks such as drowsiness, nausea, and dizziness.
Patients should report significant changes in pain, function, or mood to their clinician, especially if new symptoms emerge or existing symptoms worsen. This enables timely review and modification of the treatment plan if needed.
In simple terms, duloxetine blocks the reuptake of serotonin and norepinephrine—two key brain chemicals involved in mood and pain signaling. This increases their availability in the brain circuits that regulate emotion and pain perception.
From a pharmacological perspective, duloxetine is a balanced SNRI. It binds to the transporters that normally clear these neurotransmitters from the space between nerve cells, prolonging their action. As a result, mood, anxiety, and pain pathways can adjust toward a more regulated state over time.
On a more detailed level, the enhanced serotonin and norepinephrine activity modulates descending pain pathways. This can dampen the transmission of pain signals from the body to the brain, which may explain duloxetine’s efficacy for certain painful syndromes.
Beyond receptor effects, duloxetine has a pharmacokinetic profile that influences onset and duration of action. It is absorbed relatively consistently and has a half-life that supports once-daily dosing for many patients, though clinicians may tailor regimens to individual needs and tolerability.
Because the exact cascade of effects can differ among people, therapeutic results are best judged by clinical response over several weeks, with attention to energy, appetite, sleep, mood, and pain symptoms. If questions arise about how the drug works for a given condition, consult a healthcare professional for clarification.
Dosing must be guided by a clinician and may depend on the condition being treated, prior therapies, and tolerability. In Ireland, duloxetine often requires a prescription and careful monitoring by a healthcare professional.
A typical approach starts with a low dose to improve tolerability, followed by gradual increases based on response. The maximum recommended daily dose is determined by the indication and individual factors, and dose adjustments may be needed for liver impairment or interactions with other medicines.
Oral capsules are the usual form of duloxetine. They are taken once daily or split into two doses in some regimens, depending on the treatment plan. It is generally advised to take the medicine at about the same time each day, with or without food, as directed by a clinician.
Common considerations include avoiding abrupt changes in dose, not stopping the medicine suddenly without medical advice, and reporting persistent or severe side effects promptly. If duloxetine is discontinued, a clinician may guide a gradual reduction to minimize withdrawal-like symptoms or mood destabilization.
In addition to the clinician’s directions, patients should disclose all medicines, vitamins, or supplements to prevent potential interactions. If liver disease or significant kidney impairment is present, dose adjustments may be necessary, and supervision becomes especially important.
Before starting duloxetine, discuss any history of liver disease, kidney disease, glaucoma, bipolar disorder, or substance-use concerns with a clinician. People with uncontrolled glaucoma or a recent monoamine oxidase inhibitor (MAOI) use require careful medical assessment before initiating therapy.
Common side effects are usually mild to moderate and tend to improve over weeks. Typical experiences include nausea, dry mouth, fatigue, dizziness, and sleep disturbances. Some people also notice decreased appetite or sweating.
More serious risks require prompt medical attention. Seek urgent help if signs of severe allergic reaction, serotonin syndrome (such as confusion, fever, sweating, agitation, tremor, or muscle stiffness), or suicidal thoughts occur, especially in younger adults or at the start of treatment.
Safety considerations also apply to interactions with other medicines and substances. Avoid abruptly combining duloxetine with MAO inhibitors and limit or avoid alcohol. Clinicians may adjust doses when other antidepressants, anticoagulants, or sedatives are used together with duloxetine.
Pregnancy and breastfeeding require careful evaluation. The potential benefits and risks should be discussed with a clinician, as duloxetine can affect fetal development and infant exposure is possible through breast milk. Check the official leaflet and consult a healthcare professional before pregnancy or lactation planning.
In pregnancy, benefits to the mother must be weighed against potential risks to the fetus. A clinician may consider alternative treatments or adjust therapy if duloxetine is deemed necessary. Breastfeeding while on duloxetine should be discussed with a clinician, as the drug can pass into breast milk.
Severe liver impairment requires cautious consideration. If liver disease is present, a clinician may adjust the dose or choose an alternative therapy, with liver function monitored during treatment.
Kidney function and age can influence duloxetine’s effects and tolerability. In older adults, a clinician may start with a lower dose and monitor closely for confusion, dizziness, or balance issues. Regular review helps ensure safety and effectiveness.
Interaction checks are essential for all populations. The medicine may interact with certain herbal supplements, over-the-counter products, and prescription drugs. If any new medicine is started, tell the clinician and pharmacist to review for interactions.
Plan to take the medicine as prescribed and avoid changing the regimen without medical advice. Sudden stopping can lead to withdrawal-like symptoms or mood instability, so tapering under supervision is common when discontinuation is needed.
Eating with or without food is often acceptable, but some people find meals help lessen stomach upset. If a dose is missed, guidance from a clinician should be followed; do not double the next dose unless advised.
Alcohol use should be discussed with a clinician, as combining alcohol with duloxetine can increase side effects such as drowsiness or dizziness and may affect mood or liver health. Never alter alcohol intake without medical advice.
Keep a current list of all medicines and supplements and share this with your pharmacist. This helps prevent interactions that could impact mood, pain control, or safety. Regular follow-up visits allow the clinician to monitor effectiveness and safety.
Store the medication as directed, away from moisture and heat, and dispose of outdated units through local pharmacy guidance. If there is any concern about a reaction or an unusual symptom, seek medical help promptly.
Understanding duloxetine alongside other serotonin-norepinephrine reuptake inhibitors (SNRIs) can help patients and clinicians select the most appropriate option for a given condition. The table below offers a concise comparison of common SNRI characteristics.
Note: The table is for educational purposes and does not replace clinical judgment. Always consult a healthcare professional for personalised advice.
| Drug | Typical indications (context) | Mechanism of action | Notes on dosing and monitoring |
|---|---|---|---|
| duloxetine | Depression, anxiety disorders, diabetic neuropathy, fibromyalgia, chronic musculoskeletal pain | SNRI: inhibits reuptake of serotonin and norepinephrine | Oral capsules; dosing tailored to condition; may require prescription; monitor liver function and interactions |
| venlafaxine | Depression, several anxiety disorders, some pain conditions | SNRI with dose-dependent selectivity for serotonin and norepinephrine | Oral; similar monitoring needs; watch for blood pressure effects at higher doses |
| desvenlafaxine | Depression | SNRI; active metabolite of venlafaxine; broad mood effects | Oral; adjust in kidney impairment; monitor for withdrawal symptoms on discontinuation |
The SNRI class shares core features, but individual drugs differ in approved indications, dosing patterns, and side effects. Your clinician can weigh these factors along with your medical history to choose appropriately. If you have questions about how duloxetine compares to another SNRI, ask your pharmacist or physician for guidance tailored to Ireland’s guidelines and your health needs.
Combining duloxetine with other antidepressants requires careful medical supervision. Some combinations can raise the risk of adverse effects, including serotonin-related reactions. If you are already taking another mood medicine, discuss the plan with your clinician and pharmacist before making changes.
If a dose is missed, do not double the next one unless advised by a clinician. Follow the prescribed plan for resuming treatment, and contact your healthcare professional if you are unsure what to do. Do not take extra tablets to catch up on days you miss.
Improvements in mood or pain may take several weeks. Some people notice early changes in sleep or energy, while others need longer to assess effectiveness. If there is no noticeable improvement after a reasonable period, consult the clinician for guidance rather than adjusting the dose yourself.
Alcohol can increase sedation and may worsen liver-related risks in some individuals. Discuss alcohol use with a clinician to determine a safe approach based on your pattern of drinking, liver health, and other medicines.
A sudden stop can cause withdrawal-like symptoms or mood changes. If stopping is necessary, a clinician will usually plan a slow taper. Do not discontinue the medicine on your own without medical advice.
Pregnancy and lactation require individualized assessment. The potential benefits to the mother must be weighed against possible risks to the fetus or infant. Discuss family planning, pregnancy, and breastfeeding with a clinician before starting or continuing treatment.
Seek advice if you experience severe side effects, signs of allergic reaction, persistent mood changes, or thoughts of self-harm. Also contact a clinician if there is unexpected bleeding, severe stomach upset, yellowing of the skin or eyes, or symptoms suggesting liver trouble. Regular follow-up appointments are important for monitoring.
Long-term use is possible for some conditions with ongoing clinical evaluation. The duration should be individualized, balancing ongoing symptom control with any emerging side effects or other health considerations. Periodic reviews with a clinician help determine how long to continue therapy.
14–21 days. Free from €173.84 .
5–9 days. €26.08
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
